Understand the Symptoms and Care Options of Irritable Bowel Syndrome (IBS-C and IBS-D)
Course Overview
Nearly 1 in 10 adults and nearly 15% of children suffer the fluctuating symptom patterns of abdominal pain, disturbed defecation, and extra-intestinal symptoms associated with Irritable Bowel Syndrome. IBS-C and IBS-D represents a significant health burden owing to direct medical costs and indirect costs. Misdiagnosis and under treatment leads to waste and unnecessary patient suffering.
Diet, stress, and other sociocultural factors can influence prevalence, health care–seeking behavior, symptoms, and treatment response. Regrettably, practicing physicians and mid-level providers do not always fully understand the pathways and treatment options available now and those in development.
Topics to be covered in this interactive seminar include:
An overview of Irritable Bowel Syndrome with Constipation and with Diarrhea
Epidemiology - Clinical Presentation and Treating Adults & Children
Pathogenesis of IBS-C and IBS-D
An updated classification system for IBS, the Rome IV diagnostic criteria
Exploring new studies on sucrase-isomaltase deficiency with IBS-D and Linoclotide for abdominal symptoms
Management of IBS Patients through Dietary approaches, Anti-spasmodic therapies, and Behavioral Approaches
Recently approved therapeutic agents for IBS-C and IBS-D
Patient care management for Advanced Discussion -practice clinicians and specialty nurse
Dates and Locations
May 1, 2024 - Costa Mesa, CA
May 8, 2024 - Houston, TX
For More Information, visit https://bit.ly/IBS24 .
A web-based, self-paced version of this seminar is also available. Go to the Registration/Information button, then scroll to the bottom of the page to register for the Enduring Material.
Registration Fees: There is no charge to participate in these programs, but pre-registration is required
This program has been developed for:
Gastroenterologists
Internists
Family Physicians
Advanced-Practice Providers and Nurse Specialists
Clinical Pharmacists
Psychologists and Clinical Social Workers
For more information:
This course is supported in part by an educational grant from Salix - a division of Bausch Health, AbbVie, Inc., and Ironwood Pharmaceuticals in accordance with ACCME accreditation Standards of Commercial Support.
Designation Statements
Physicians (MD/DO)- The University of Louisville Office of Continuing Medical Education & Professional Development designates Symptoms and Care Options of IBS as a live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses- The Symptoms and Care Options of IBS seminar has been approved for 1.2 Continuing Education Credits through the University of Louisville Hospital, provider number 4-0068-12-24-1382.
AANP accepts Category I credit from AMA PRA Category 1 Credit(s)™ organizations accredited by ACCME.
Go to the Registration/Information button, then scroll to the bottom of the page to register for the Enduring Material.
Physicians Assistants - AAPA accepts Category I credit from AMA PRA Category 1 Credit(s)™ organizations accredited by ACCME.
For the Enduring Material, go to the Registration.Information button, then scroll to the bottom of the page to register and access the course.
For Course or Content Information, please contact SCLRC at cme@scliver.com or at (253) 432-4023
To Register for these programs, please contact the University of Louisville
University of Louisville Office of CME and Professional Development
501 E. Broadway Su 370
Louisville, KY 40202
Phone: (502) 852-5329
Email: cmepd@louisville.edu
